Your email has been successfully added to our mailing list.

×
0.00109529025191673 0.012354874041621 0.012354874041621 -0.00109529025191673 -0.0131434830230012 -0.0120481927710845 -0.0317634173055861 -0.0251916757940855
Stock impact report

Your Daily Pharma Scoop: ResTORbio Progresses, Roche Closer To Review, AbbVie Falters [Seeking Alpha]

RESTORBIO (TORC) 
Last restorbio earnings: 3/12 07:30 am Check Earnings Report
Company Research Source: Seeking Alpha
Summary Stocks in News: TORC, RHHBY ResTORbio's RTB101 shows treatment benefit in mid-stage study; shares up 9% Discussion : ResTORbio ( TORC ) announced positive results from a Phase 2a clinical trial of its lead drug RTB101 in elderly patients. The candidate was on trial testing its infection-lowering ability. The datasets were published in Science Translational Medicine. The study showed that RTB101 both as monotherapy as well as in combination with Novartis’s Afinitor (everolimus), showed statistically significant reduced rate of respiratory tract infections. The combination therapy also clearly enhanced the response to influenza vaccination and favourably affected the expression of genes playing key role in helping the immune system fight respiratory tract infections. Topline data from the trial is expected in Q3 2018. TORC1 is a multiprotein complex engaged in intracellular signalling pathway called mTOR. The company claims that animal studies to have shown t Show less Read more
Impact Snapshot
Event Time:
TORC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for TORC alerts
Opt-in for
TORC alerts

from News Quantified
Opt-in for
TORC alerts

from News Quantified